Nahya Salim

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Michael White, Robert Verity, Jamie T. Griffin et al. · The Lancet Infectious Diseases · 2015 · 344 citations · Full text

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

Salim Abdulla, Rolf Oberholzer, Omar Juma et al. · New England Journal of Medicine · 2008 · 238 citations · Full text

Diagnostic Accuracy of Kato–Katz, FLOTAC, Baermann, and PCR Methods for the Detection of Light-Intensity Hookworm and Strongyloides stercoralis Infections in Tanzania

Stefanie Knopp, Nahya Salim, Tobias Schindler et al. · American Journal of Tropical Medicine and Hygiene · 2014 · 149 citations · Full text

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante, Salim Abdulla, Sélidji Todagbé Agnandji et al. · The Lancet Infectious Diseases · 2011 · 134 citations

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data

Philip Bejon, Michael White, Ally Olotu et al. · The Lancet Infectious Diseases · 2013 · 111 citations · Full text